SCHEMBL13069286

SCHEMBL13069286

CC(=O)[C@@]1(O)CCC2C3C[C@H](C)C4=CC(=O)CC[C@]4(C)C3(F)[C@@H](O)C[C@@]21C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 7/20 0.67
HIF1A Q16665 6/20 0.67
LMNA P02545 5/20 0.67
CYP3A4 P08684 3/20 0.67
PGR P06401 3/20 0.67
CYP2C9 P11712 2/20 0.67
NR1I2 O75469 1/20 0.67
GAA P10253 1/20 0.67
HTT P42858 1/20 0.67
HSD17B10 Q99714 2/20 0.58
TSHR P16473 1/20 0.58
ALDH1A1 P00352 1/20 0.58
HRH1 P35367 1/20 0.55
MEN1 O00255 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C19 P33261 2/20 0.55
KMT2A Q03164 2/20 0.55
AR P10275 2/20 0.53
SERPINA6 P08185 2/20 0.51
FNTA P49354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13069231 1.00 NR3C1 (0.67) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL9627974 0.90 NR3C1 (0.57) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL9627979 0.90 NR3C1 (0.57) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL11859348 0.90 NR3C1 (0.72) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL11859370 0.90 NR3C1 (0.72) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL13069234 0.89 NR3C1 (0.55) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL8642587 0.84 NR3C1 (0.61) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL8641244 0.84 NR3C1 (0.61) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL13069232 0.83 NR3C1 (0.80) NR3C1HIF1ALMNACYP3A4PGR
SCHEMBL21231580 0.83 NR3C1 (0.80) NR3C1HIF1ALMNACYP3A4PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246359-A1 Process for obtaining fluorometholone and intermediates therefor Crystal Pharma, S.L.U. (ES) 2010-11-03 EP disclosed
WO-2010122096-A1 PROCESS FOR OBTAINING FLUOROMETHOLONE AND INTERMEDIATES THEREFOR CRYSTAL PHARMA, S.L.U. (ES) 2010-10-28 WO disclosed